Product Program year 2020 Source: CMS Open Payments

Mk-4280

Biological Oncology

Open in the dashboard

General payments

$169,493

44 payments

Research payments

$9,469,747

4,054 payments

Through program year 2020, $169,493 in general payments and $9,469,747 in research payments were reported against Mk-4280 (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $67,710 13
2020 Research $5,124,175 1,496
2019 General $101,783 31
2019 Research $4,345,572 2,558

Breakdown

Who paid General payments · program years 2019–2020
  1. Merck Sharp & Dohme Corporation $169,493 44 payments
Top recipients General payments · program year 2020
  1. Robert Smith Diagnostic Radiology · New Hyde Park, NY $25,960 38% · 3 payments
  2. Ryan Murtagh Diagnostic Neuroimaging · El Segundo, CA $17,700 26% · 3 payments
  3. Lisa Jones Diagnostic Radiology · Philadelphia, PA $16,200 24% · 3 payments
  4. Craig Kolodziej Diagnostic Radiology · Boca Raton, FL $7,850 12% · 4 payments

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Diagnostic Radiology Radiology $50,010 74% · 3 practitioners
  2. Diagnostic Neuroimaging Radiology $17,700 26% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New York $25,960 38% · 1 recipient
  2. Florida $25,550 38% · 2 recipients
  3. Pennsylvania $16,200 24% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

44 general · 4,054 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record